<DOC>
	<DOC>NCT02865837</DOC>
	<brief_summary>The purpose of this study is to compare, for each patient, dosimetry of organs at risk (bladder, rectum, sigmoid, small bowel) in two bladder distension procedures (emptied by a urinary catheter or filled with 120cc) during PDR 3D image-guided brachytherapy of cervical cancer.</brief_summary>
	<brief_title>Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Urinary Retention</mesh_term>
	<criteria>Age &gt; or = 18 years old with a cervical cancer histologically proven (squamous cell carcinoma, adenocarcinoma and neuroendocrine cell carcinoma) Uterovaginal brachytherapy indications:: Stage 1B1: brachytherapy before surgery Stages IB2 to IIIB: after pelvic radiotherapy (45Gy/25 fractions/5 weeks) with or without concomitant chemotherapy Ability to provide an informed written consent form Patient must be affiliated to a social security system Age &lt; 18 years old History of pelvic radiotherapy History of pelvic surgery Recent joint prothesis (&lt;3 months) Pregnant woman or being breastfeeding Patients deprived of liberty or under supervision</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Brachytherapy</keyword>
	<keyword>Organs at Risk</keyword>
	<keyword>Bladder volume</keyword>
	<keyword>Cervical cancer</keyword>
</DOC>